Literature DB >> 11451040

Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin.

T Sakai1, K Yamasaki, T Sako, U Kragh-Hansen, A Suenaga, M Otagiri.   

Abstract

PURPOSE: The study was performed for clarifying the mechanism of interaction between indoxyl sulfate (IS), a typical uremic toxin bound to site II, and site I-ligands when bound to human serum albumin (HSA). The effect of the N to B transition on the interactions was also examined.
METHODS: Quantitative investigation of the relations between ligands bound to HSA was performed by equilibrium dialysis, and the binding data were analyzed on the basis of a theoretical model for simultaneous binding of two ligands.
RESULTS: The high-affinity binding constants for the site I-ligands warfarin (WF) and dansyl-L-asparagine (DNSA) increased with increasing pH, whereas those for the site II-ligands IS and dansylsarcosine (DNSS) were hardly affected by pH. Mutual displacement experiments showed that even though IS binds to site II it influenced binding of DNSA at the azapropazone binding area in site I. By contrast, it is unlikely that IS affects the WF binding area of site I. Furthermore, pH-profiles showed that the interaction between IS and DNSA was very sensitive to the N to B transition: "competitive-like" strong allosteric regulation was observed for binding of the two ligands to the N conformer (pH 6.5), whereas in the B conformation (pH 8.5) binding of these molecules was nearly "independent".
CONCLUSIONS: The present data provide useful information for elucidating a potential mechanism of interaction between drugs and endogenous substances including uremic toxins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451040     DOI: 10.1023/a:1011014629551

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Independent binding of ligands to human serum albumin.

Authors:  R Brodersen; T Sjödin; I Sjöholm
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

2.  The molecular mechanism of the neutral-to-base transition of human serum albumin. Acid/base titration and proton nuclear magnetic resonance studies on a large peptic and a large tryptic fragment of albumin.

Authors:  O J Bos; J F Labro; M J Fischer; J Wilting; L H Janssen
Journal:  J Biol Chem       Date:  1989-01-15       Impact factor: 5.157

3.  Relations between high-affinity binding sites of markers for binding regions on human serum albumin.

Authors:  U Kragh-Hansen
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

4.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

5.  The role of albumin conformation in the binding of diazepam to human serum albumin.

Authors:  J Wilting; B J Hart; J J De Gier
Journal:  Biochim Biophys Acta       Date:  1980-12-16

6.  Characterization of binding site of uremic toxins on human serum albumin.

Authors:  T Sakai; A Takadate; M Otagiri
Journal:  Biol Pharm Bull       Date:  1995-12       Impact factor: 2.233

7.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites.

Authors:  S Curry; H Mandelkow; P Brick; N Franks
Journal:  Nat Struct Biol       Date:  1998-09

8.  Removal of fatty acids from serum albumin by charcoal treatment.

Authors:  R F Chen
Journal:  J Biol Chem       Date:  1967-01-25       Impact factor: 5.157

9.  Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition.

Authors:  K Yamasaki; T Maruyama; K Yoshimoto; Y Tsutsumi; R Narazaki; A Fukuhara; U Kragh-Hansen; M Otagiri
Journal:  Biochim Biophys Acta       Date:  1999-07-13

10.  The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis.

Authors:  J Wilting; W F van der Giesen; L H Janssen; M M Weideman; M Otagiri; J H Perrin
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

View more
  15 in total

Review 1.  The role of the protein-binding on the mode of drug action as well the interactions with other drugs.

Authors:  Christine Tesseromatis; Anastasia Alevizou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

2.  Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.

Authors:  Magdalena Madero; Karla B Cano; Israel Campos; Xia Tao; Vaibhav Maheshwari; Jillian Brown; Beatriz Cornejo; Garry Handelman; Stephan Thijssen; Peter Kotanko
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-12       Impact factor: 8.237

3.  Stress can affect drug pharmacokinetics via serum/tissues protein binding and blood flow rate alterations.

Authors:  Kotsiou Antonia; Alevizou Anastasia; Christine Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-12-16       Impact factor: 2.441

4.  p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

Authors:  Björn K I Meijers; Henriette De Loor; Bert Bammens; Kristin Verbeke; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 8.237

5.  Increased Plasma Concentrations of Unbound SN-38, the Active Metabolite of Irinotecan, in Cancer Patients with Severe Renal Failure.

Authors:  Ken-ichi Fujita; Yusuke Masuo; Hidenori Okumura; Yusuke Watanabe; Hiromichi Suzuki; Yu Sunakawa; Ken Shimada; Kaori Kawara; Yuko Akiyama; Masanori Kitamura; Munetaka Kunishima; Yasutsuna Sasaki; Yukio Kato
Journal:  Pharm Res       Date:  2015-09-03       Impact factor: 4.200

6.  Albumin-binding PARACEST agents.

Authors:  M Meser Ali; Mark Woods; Eul Hyun Suh; Zoltan Kovacs; Gyula Tircsó; Piyu Zhao; Vikram D Kodibagkar; A Dean Sherry
Journal:  J Biol Inorg Chem       Date:  2007-05-30       Impact factor: 3.358

7.  Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin.

Authors:  Ali J Ryan; Jamie Ghuman; Patricia A Zunszain; Chun-wa Chung; Stephen Curry
Journal:  J Struct Biol       Date:  2010-10-19       Impact factor: 2.867

8.  An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure.

Authors:  Kazuki Shimoishi; Makoto Anraku; Kenichiro Kitamura; Yuka Tasaki; Kazuaki Taguchi; Mitsuru Hashimoto; Eiko Fukunaga; Toru Maruyama; Masaki Otagiri
Journal:  Pharm Res       Date:  2007-03-27       Impact factor: 4.580

9.  Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albumin.

Authors:  Paolo Ascenzi; Loris Leboffe; Alessandra di Masi; Viviana Trezza; Gabriella Fanali; Magda Gioia; Massimo Coletta; Mauro Fasano
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

10.  Binding affinity and capacity for the uremic toxin indoxyl sulfate.

Authors:  Eric Devine; Detlef H Krieter; Marieke Rüth; Joachim Jankovski; Horst-Dieter Lemke
Journal:  Toxins (Basel)       Date:  2014-01-24       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.